Search filters

List of works by Samer A Srour

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

scientific article published on 9 May 2017

Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

scientific article published on 01 October 2020

Can we cure refractory Hodgkin's lymphoma with transplantation?

scientific article published on 07 July 2020

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

scientific article published on 11 January 2019

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

scientific article published on 30 June 2020

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hemaptopoietic Stem Cell Transplantation

scientific article published in 2022

Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation

scientific article published on 09 February 2020

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

scientific article published on 01 November 2018

Haploidentical Transplants for Patients with Graft Failure After the First Allograft

scientific article published on 29 June 2020

Haploidentical Transplants for Patients with Relapse After the First Allograft

scientific article published on 03 July 2020

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

scientific article published on 21 October 2019

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

scientific article published on 01 April 2020

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis

scientific article published on 03 September 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation

scientific article published on 11 July 2019

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

scientific article published on 04 April 2019

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

scientific article published on 10 September 2019

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis

scientific article published on 24 December 2019

Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation

scientific article

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant

scientific article published on 15 July 2016

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

scientific article published on 9 November 2016